Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer (PARTIQoL)

This study is currently recruiting participants. (see Contacts and Locations)
Verified April 2016 by Massachusetts General Hospital
University of Pennsylvania
National Cancer Institute (NCI)
Northwestern University
M.D. Anderson Cancer Center
ProCure Proton Therapy Center
Washington University School of Medicine
University of Washington
Memorial Sloan Kettering Cancer Center
Rutgers Cancer Institute of New Jersey
Provision Proton Therapy Center
Information provided by (Responsible Party):
Jason Efstathiou, Massachusetts General Hospital Identifier:
First received: June 8, 2012
Last updated: April 21, 2016
Last verified: April 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: December 2018 (Final data collection date for primary outcome measure)